CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

118 hedge funds and large institutions have $396M invested in Cymabay Therapeutics in 2022 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 30 increasing their positions, 29 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
118
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.79M
Puts
$1.5M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
76
$251K
77
$249K
78
$217K
79
$180K
80
$170K
81
$157K
82
$157K
83
$156K
84
$156K
85
$153K
86
$147K
87
$145K
88
$114K
89
$113K
90
$113K
91
$93.5K
92
$80.9K
93
$73K
94
$70.5K
95
$66K
96
$63K
97
$62.9K
98
$39K
99
$38.6K
100
$29.4K